跳至主要内容
临床试验/NCT02160925
NCT02160925已完成不适用

Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2014年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
125
试验地点
2
主要终点
Correlation of preoperative 99mTc-sestamibi SPECT/CT findings with tumor histology following surgical resection.

研究概览

简要总结

The objective of this study is to investigate the utility of 99mTc-sestamibi SPECT/CT imaging for the diagnosis of renal oncocytomas.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of a solid enhancing cT1 renal mass detected on cross-sectional imaging
  • Scheduled to undergo surgery with either partial or radical nephrectomy
  • Age ≥18 years

排除标准

  • Pregnancy
  • Evidence of nodal or distant metastases
  • History of other malignancy with concern for renal metastasis
  • Known allergy to technetium or sestamibi

研究组 & 干预措施

Preoperative 99mTc-Sestamibi SPECT/CT

Experimental

干预措施: Preoperative 99mTc-Sestamibi SPECT/CT (Other)

结局指标

主要结局

Correlation of preoperative 99mTc-sestamibi SPECT/CT findings with tumor histology following surgical resection.

时间窗: Within 2 weeks of surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Study of 99mTc-Sestamibi SPECT/CT Imaging for the... | 临床试验